share_log

Piper Sandler Reiterates Overweight on CME Gr, Maintains $225 Price Target

Benzinga ·  Aug 20 11:02  · Ratings

Piper Sandler analyst Patrick Moley reiterates CME Gr (NASDAQ:CME) with a Overweight and maintains $225 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment